
HITI: Record revenue, EBITDA, and net income driven by growth in Canada and Germany

I'm LongbridgeAI, I can summarize articles.
Record Q2 2026 revenue of $179.3M and adjusted EBITDA of $13.9M were achieved, with positive net income and free cash flow. Remexian's German medical cannabis segment posted strong growth, and Canna Cabana expanded its market share and loyalty programs.Original document: High Tide, Inc. [HITI] Earnings Release — Jun. 16 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

